Designing a placebo device: Involving service users in clinical trial design

Health Expectations

Volumn 16, Issue 4, 2013, Pages

  Gooberman Hill, Rachael ^a   Jinks, Clare ^b   Bouças, Sofia Barbosa ^c   Hislop, Kelly ^c   Dziedzic, Krysia S ^b   Rhodes, Carol ^b   Burston, Amanda ^a   Adams, Jo ^c  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b KEELE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Device design; Hand; Osteoarthritis; Placebo; Service user involvement; Splint

Indexed keywords

PLACEBO;

AGED; ARTICLE; DEVICE DESIGN; EQUIPMENT; EQUIPMENT DESIGN; FEMALE; HAND; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; OSTEOARTHRITIS; PATIENT PARTICIPATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SERVICE USER INVOLVEMENT; SPLINT; THUMB;

DEVICE DESIGN; HAND; OSTEOARTHRITIS; PLACEBO; SERVICE USER INVOLVEMENT; SPLINT;

AGED; EQUIPMENT DESIGN; FEMALE; HAND; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS; PATIENT PARTICIPATION; PLACEBOS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SPLINTS; THUMB;

EID: 84888008350     PISSN: 13696513     EISSN: 13697625     Source Type: Journal    
DOI: 10.1111/hex.12043     Document Type: Article

References (46)

1. Lambert H. Evidentiary truths? The evidence of anthropology through the anthropology of medical evidence. Anthropology Today, 2009; 25: 16-20.
2. Boote J, Barber R, Cooper C. Principles and indicators of successful consumer involvement in NHS research: results of a Delphi study and subgroup analysis. Health Policy, 2006; 75: 280-297.
3. Buckland S, Hayes H, Ostrer C et al. How to get Actively Involved in NHS, Public Health and Social Care Research. Eastleigh: INVOLVE, 2007.
4. de Wit MP, Berlo SE, Aanerud GJ et al. European League Against Rheumatism recommendations for the inclusion of patient representatives in scientific projects. Annals of the Rheumatic Diseases, 2011; 70: 722-726.
5. Boote J, Baird W, Sutton A. Public involvement in the design and conduct of clinical trials: a review. International Journal of Interdisciplinary Social Sciences, 2011; 5: 91-111.
6. Craig P, Dieppe P, Macintryre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ, 2008; 337: a1655.
7. Angell KL, Kreshka MA, Donnelly P et al. Psychosocial intervention for rural women with breast cancer. Journal of General Internal Medicine, 2003; 18: 499-507.
8. Marsden P, Bradburn J. The Consumers' Advisory Group for Clinical Trials (CAG-CT), the Lynda Jackson Macmillan Centre Patient and clinician collaboration in the design of a national randomized breast cancer trial. Health Expectations, 2004; 7: 6-17.
9. Lambert H. Accounting for EBM: notions of evidence in medicine. Social Science and Medicine, 2006; 62: 2633-2645.
10. Kennedy A, Reeves D, Bower P et al. The effectiveness and cost effectiveness of a national lay-led self care support programme for patients with long-term conditions: a pragmatic randomised controlled trial. Journal of Epidemiology and Community Health, 2007; 61: 254-261.
11. Dziedzic KS, Hill S, Nicholls E et al. Self management, joint protection and exercises in hand osteoarthritis: a randomised controlled trial with cost effectiveness analyses. BMC Musculoskeletal Disorders, 2011; 12: 156.
12. Minns Lowe CJ, Barker KL, Dewey M, Sackley CM. Effectiveness of physiotherapy exercise after knee arthroplasty for osteoarthritis: systematic review and meta-analysis of randomised controlled trials. BMJ, 2007; 335: 812.
13. Eccleston C, Williams AC, Morley S. Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database of Systematic Reviews, 2012.
14. Moerman D. Meaning, Medicine and the 'Placebo Effect'. Cambridge: Cambridge University Press, 2002.
15. Doherty M, Dieppe P. The 'placebo' response in osteoarthritis and its implications for clinical practice. Osteoarthritis Cartilage, 2009; 17: 1255-1262.
16. Kaptchuk TJ. Powerful placebo: the dark side of the randomised controlled trial. Lancet, 1998; 351: 1722-1725.
17. Miller FG, Kaptchuk TJ. The power of context: reconceptualising the placebo effect. Journal of the Royal Society of Medicine, 2008; 101: 222-225.
18. Geers AL, Weiland PE, Kosbab K, Landry SJ, Helfer SG. Goal activation, expectations, and the placebo effect. Journal of Personality and Social Psychology, 2005; 89: 143-159.
19. Edwards SJL, Stevens AJ, Braunholtz DA, Lilford RJ, Swift T. The ethics of placebo-controlled trials: a comparison of inert and active placebo controls. World Journal of Surgery, 2005; 29: 610-614.
20. Foster NE, Thomas E, Barlas P et al. Acupuncture as an adjunct to exercise based physiotherapy for osteoarthritis of the knee: randomised controlled trial. BMJ, 2007; 335: 436.
21. Paterson C, Dieppe P. Characteristic and incidental (placebo) effects in complex interventions such as acupuncture. BMJ, 2005; 330: 1202-1205.
22. Campbell MK, Entwistle VA, Cuthbertson BH et al. Developing a placebo-controlled trial in surgery: issues of design, acceptability and feasibility. Trials, 2011; 12: 50.
23. Stamm T, van der Gisesn F, Thorstensson C et al. Patient perspective of hand osteoarthritis in relation to concepts covered by instruments measuring functioning: a qualitative European multicentre study. Annals of the Rheumatic Diseases, 2009; 68: 1453-1460.
24. Kjeken I, Smedslund G, Moe RH et al. Systematic review of design and effects of splints and exercise programs in hand osteoarthritis. Arthritis Care and Research, 2011; 63: 834-848.
25. Pereira D, Peleteiro B, Araujo J, Branco J, Santos RA, Ramos E. The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review. Osteoarthritis Cartilage, 2011; 19: 1270-1285.
26. Zhang Y, Niu J, Kelly-Hayes M, Chaisson CE, Aliabadi P, Felson DT. Prevalence of symptomatic hand osteoarthritis and its impact on functional status among the elderly. American Journal of Epidemiology, 2002; 156: 1021-1027.
27. Dziedzic KS, Thomas E, Hill S, Wilkie R, Peat G, Croft PR. The impact of musculoskeletal hand problems in older adults: findings from the North Staffordshire Osteoarthritis Project (NorStOP). Rheumatology, 2007; 46: 963-967.
28. National Collaborating Centre for Chronic Conditions. Osteoathritis: The Care and Management of Osteoarthritis in Adults. Nice Clinical Guideline 59, London: National Collaborating Centre for Chronic Conditions, 2008.
29. Ye L, Kalichman L, Spittle A, Dobson F, Bennell K. Effects of rehabilitative interventions on pain, function and physical impairments in people with hand osteoarthritis: a systematic review. Arthritis Research and Therapy, 2011; 13: R28.
30. Dziedzic KS. Osteoarthritis: best evidence for best therapies in hand osteoarthritis. Nature Reviews Rheumatology, 2011; 7: 258-260.
31. Hill S, Dziedzic KS, Ong BN. Patients' perceptions of the treatment and management of hand osteoarthritis: a focus group enquiry. Disability and Rehabilitation, 2011; 33: 1866-1872.
32. Fess EE. A history of splinting: to understand the present, view the past. Journal of Hand Therapy, 2002; 15: 97-132.
33. Adams J Orthotics of the hand. In: Dziedzic K, Hammond A (eds) Rheumatology: Evidence-based Practice for Physiotherapists and Occupational Therapists. London: Elsevier Ltd, 2010: 163-170.
34. Avins AL, Cherkin DC, Sherman KJ, Goldberg H, Pressman A. Should we reconsider the routine use of placebo controls in clinical research? Trials, 2012; 13: 44.
35. Multidisciplinary Assessment of Technology Centre for Healthcare (MATCH) User requirements during the product development pathway. Available at: http://match-guide.brunel.ac.uk/development.aspx, accessed 8 November 2011.
36. Ram M, Grocott PR, Weir HCM. Issues and challenges of involving users in medical device development. Health Expectations, 2008; 11: 63-71.
37. INVOLVE. What You Need to Know About Payment: An Introductory Guide for Members of the Public who are Considering Active Involvement in NHS, Public Health or Social Care Research. Eastleigh: INVOLVE, 2011. Available at: http://www.invo.org.uk/wp-content/uploads/2011/06/INVOLVEpaymentdocument2011.pdf, accessed 12 March 2012.
38. Rowe G, Frewer LJ. A typology of public engagement mechanisms. Science, Technology and Human Values, 2005; 30: 251-290.
39. Tarpey M. Public Involvement in Research Applications to the National Research Ethics Service. Eastleigh: INVOLVE, 2011.
40. Vale CL, Thompson LC, Murphy C, Forcat S, Hanley B. Involvement of consumers in studies run by the Medical Research Council Clinical Trials Unit: results of a survey. Trials, 2012; 13: 9.
41. Hanley B, Truesdale A, King A, Elbourne D, Chalmers I. Involving consumers in designing, conducting, and interpreting randomised controlled trials: questionnaire survey. BMJ, 2001; 322: 519-523.
42. Hansson SO. Uncertainty and the ethics of clinical trials. Theoretical Medicine and Bioethics, 2006; 27: 149-167.
43. Staniszewska S, Brett J, Mockford C, Barber R. The GRIPP checklist: strengthening the quality of patient and public involvement reporting in research. International Journal of Technology Assessment in Health Care, 2011; 27: 391-399.
44. INVOLVE. What is Public Involvement in Research. Available at: http://www.invo.org.uk/find-out-more/what-is-public-involvement-in-research-2/, accessed 11 October 2012.
45. McIntyre A. Participatory Action Research: A Qualitative Research Methods Series 52. Los Angeles, CA: Sage, 2008.
46. Gooberman-Hill A. Qualitative approaches to understanding patient preferences. The Patient-Patient-Centered Outcomes Research, 2012; 5: 215-223.